NEW YORK (GenomeWeb News) – The American Medical Association and McKesson announced a licensing deal today to create a reference product for identifying and tracking molecular diagnostic tests.

The deal calls for McKesson Z-Code Identifiers to be grouped and indexed with corresponding molecular pathology codes in the AMA's Current Procedural Terminology code set. With the resulting reference product, "the healthcare industry can better understand the growth in this area to support advanced diagnostics innovation," AMA and McKesson said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.